Cargando…
Elafin and its precursor trappin‐2: What is their therapeutic potential for intestinal diseases?
Elafin and its precursor trappin‐2 are known for their contribution to the physiological mucosal shield against luminal microbes. Such a contribution seems to be particularly relevant in the gut, where the exposure of host tissues to heavy loads of microbes is constant and contributes to mucosa‐asso...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098471/ https://www.ncbi.nlm.nih.gov/pubmed/36355635 http://dx.doi.org/10.1111/bph.15985 |